Cefuroxime is a new broad-spectrum cephalosporin antibiotic with increased stability to f8-lactamases. This stability, although no absolute in all cases, has the effect of widening the antibacterial spectrum of the compound so that many organisms resistant to the established cephalosporins are susceptible to cefuroxime. It is active against gram-positive organisms, including penicillinaseproducing staphylococci, but it is less active against methicillin-resistant strains. In addition to its high activity against non-,8-lactamase-producing gram-negative bacteria, cefuroxime effectively inhibits the growth of many 1B-lactamase-producing strains, including Enterobacter, Klebsiella, and indole-positive Proteus spp. It is highly active against Neisseria gonorrhoeae, Neisseria meningitidis, and also Haemophilus influenzae, including ampicillin-resistant strains. Cefuroxime is rapidly bactericidal and induces the formation and subsequent lysis of filamentous forms over a small concentration range.
gram-negative bacteria, cefuroxime effectively inhibits the growth of many 1B-lactamase-producing strains, including Enterobacter, Klebsiella, and indole-positive Proteus spp. It is highly active against Neisseria gonorrhoeae, Neisseria meningitidis, and also Haemophilus influenzae, including ampicillin-resistant strains. Cefuroxime is rapidly bactericidal and induces the formation and subsequent lysis of filamentous forms over a small concentration range.
All the cephalosporins in current clinical use have some limitations in their spectrum of antibacterial activity. None is very active against Neisseria or Haemophilus infZuenzae, whereas poor activity against many gramnegative bacilli can often be attributed to destruction by 4-lactamases. Other deficiencies encountered among this group of antibiotics include metabolic instability and high binding to serum proteins. Cefuroxime, 6R,7R-3-carbamoyloxymethyl-7-(2Z)-2-methoxyimino (fur-2-yl) acetamido-ceph-3-em-4-carboxylate, is a new semisynthetic cephalosporin analogue that overcomes some of these disadvantages. Its structure is given in Fig. 1 .
MATERIALS AND METHODS Antibiotics. Cefuroxime sodium was prepared in our own laboratories as a creamy white crystalline solid with a molecular weight of 446.4; it is approximately 20% soluble in water. Cephaloridine, cephalothin, and cephalexin were commercially available materials made by Glaxo Laboratories Ltd.; cefazolin (Totacef, Bristol Laboratories) and ampicillin were purchased.
Organisms. Most of the organisms tested were recent clinical isolates from Westminster Hospital (London), London Hospital, Papworth Hospital (Cambridge), and Southmead Hospital (Bristol). Strains of H. influenzae were given to us by P. Cavanagh of the Public Health Laboratory, Stokeon-Trent.
Disk susceptibility testing. Strains of bacteria were tested for susceptibility to the antibiotics by a standardized disk technique described by Ericsson and Sherris (2), using Oxoid agar no. 1 (Oxoid Ltd., London).
MIC determinations. Minimum inhibitory concentrations (MICs) were determined by an agar dilution technique, in parallel tests with cephalothin. Serial twofold dilutions of freshly prepared standard antibiotic solutions were made into Oxoid no. 1 nutrient agar with or without added enrichment and poured into petri dishes. Plates were inoculated with a replicate inoculating device (Denley Instruments Ltd., Bolney, Sussex) with inocula containing approximately 105 or 107 colonyforming units. The MIC, in micrograms per milliliter, was read after 18 h of incubation at 37 C as the lowest concentration that inhibited growth.
Correlation of MIC values with disk test results. The MIC values obtained by the agar plate technique were plotted against zone diameters obtained with disks containing 30 ,ug of antibiotic. From these experimental points a regression curve, calculated by the method of least squares, was drawn for each compound.
Growth studies. Various concentrations of antibiotics were added to actively growing cultures in a Jouan biophotometer, and growth was followed by optical density measurements and viable counts. Samples removed at various times were examined under the microscope for morphological variants. The medium used was mainly Oxoid nutrient broth, but casein-yeast extract (CY) medium was used for strains of Proteus.
Detection of f8-lactamase activity. All bacterial cultures were examined for 1-lactamase production using the chromogenic cephalosporin described by O'Callaghan et al. (9 that produced a (3-lactamase had much the same susceptibility to cefuroxime as those that did not, whereas the 18-lactamase-producing strains were much more resistant to cephalothin. Klebsiella spp. were also susceptible to cefuroxime, with more than 80% of strains tested susceptible to 16 ,ug/ml or less. Its activity against various Enterobacter spp. was particularly good; most of these organisms were f8-lactamase producers, rendering them unsusceptible to cephalothin. However, members of the Serratia group were resistant to both antibiotics.
Strains of Proteus mirabilis were very susceptible to both compounds, 75% of the strains being inhibited by 2 ,ug/ml or less. Cefuroxime had a geometric mean MIC of 27 ,ug/ml for indole-positive strains of Proteus; these organisms produced an inducible 83-lactamase and were completely unsusceptible to cephalothin. The activity of cefuroxime and cephalothin was essentially the same against Salmonella spp., but cefuroxime was the more active compound against the strains of Shigella tested, even when the organisms were not (3-lactamase producers. Both compounds had relatively poor activity against Bacteroides fragilis and none against P. aeruginosa.
Unlike most cephalosporins, cefuroxime had good activity against H. influenzae, including the strains resistant to ampicillin because they produce a class III (3-lactamase (11) , which is very similar to that mediated by the transmissible R -factor RrEM (11) . A further interesting feature of cefuroxime is its high activity against Neisseria gonorrhoeae and N. meningitidis strains.
Effect of inoculum size. Increasing the size of the inoculum from 105 to 107 colony-forming units had little effect on the activity of cefuroxime against the majority of strains tested (Table 3) , although against the two proteus strains the inoculum effect was quite large. The activity of the other cephalosporins was considerably diminished when high inoculum levels were used.
Regression line analysis. Regression lines and equations correlating MIC values with zone diameters by the agar dilution method are shown in Fig. 2 . The values for cefuroxime against most of the organisms tested fall close to the line, so that in general there is good correlation between zone size and MICs.
Growth studies. Cefuroxime was bactericidal to most organisms at a concentration identical with, or close to, the MIC. This was confirmed by viable counts, which were done with a range of organisms, the counts being made at 0, 2, 4, and 6 h after inoculation. cefuroxime was rapidly bactericidal. Like most cephalosporins, its action was comparatively slow against the strains of S. aureus but, even so, over 99% of the initial inoculum was killed by 6 h. The gram-negative organisms were killed rapidly, and in most cases over 99% of the very large inocula were killed within 2 h; the 3-lactamase-producing strains were killed as quickly as non-enzyme-producing strains. Turbidimetric measurements on growing cultures showed that there was always a period of increase in opacity after the compound had been added, which varied from species to species. Lysis then occurred rapidly, with the opacity of the culture falling below the sensitivity of the instrument. The rate of lysis was slower for staphylococci than for gram-negative organisms, which is consistent with the effect on the viable counts. Some examples are shown in Fig. 3 and 4 . All susceptible organisms tested were lysed by cefuroxime, including N. gonorrhoeae and H. influenzae.
The rate of lysis of gram-negative organisms by 13-lactam antibiotics has been shown to depend to varying degrees upon the osmolality of the medium used (4), and strains of Proteus are particularly susceptible to this effect. The example shown in Fig. 4 shows that cefuroxime lysed the organisms much more effectively in CY medium than in nutrient broth, which has a higher osmolality.
Microscopic examination of various gramnegative organisms growing in low concentrations of cefuroxime showed that many of them produced filamentous forms over a concentration range between one-fourth and four times the MIC.
Stability to f3-lactamases. Eleven partially purified (8-lactamase preparations were tested for their ability to hydrolyze cefuroxime and three other cephalosporin antibiotics. The results in Table 5 show that cefuroxime was more stable to all the enzymes than the other compounds tested. Only three of the enzymes tested were able to hydrolyze cefuroxime relatively rapidly; these were the class IV enzyme produced by certain strains of K. aerogenes, a class I type of enzyme produced by some strains of B. fragilis (1) , and the enzyme complex produced by B. cereus 659/H9 (5). Cefuroxime was unaffected by the ,8-lactamase from S. aureus, whereas enzyme hydrolysis of the other compounds was detected.
Effect of liver esterases on cefuroxime. Cefuroxime has an ester group at position 3 ( Fig. 1) but, unlike cephalothin and the 3-acetoxymethyl analogues of cefuroxime, it does not lose any antibacterial activity when incubated for 4 h with homogenates of mouse, rat, rabbit, or human liver (Table 6 ). Chromatography of the reaction mixtures, followed by bioautography, confirmed that cefuroxime remained unchanged, whereas both cephalothin and the 3-acetoxymethyl analogue cefuroxime were converted into different compounds with reduced antibacterial activity. This stability is similar to that shown by cefoxitin, which also has a carbamate group at position 3 (C. S. Goodwin, E. B. Raftery, H. Skeggs, A. E. Hill, and C. M. Martin, Prog. Abstr. Intersci. Conf. Antimicrob. Agents Chemother., 13th, Washington, D.C., Abstr.
51, 1973).
Effect of human serum. Thirty-three per-VOL. 9, 1976 on November 3, 2017 by guest http://aac.asm.org/ cent of cefuroxime was bound to human serum proteins, which is a little higher than the serum binding of cephaloridine but much lower than that of cephalothin and cefazolin, at 70 and 80%, respectively ( Table 7) . The presence of human serum in the growth medium had little effect on the antibacterial activity of Richmond and Sykes (12) . b Activity is expressed as micrograms destroyed per hour. (Table 5) , having a level of activity against most of the enzyme-producing strains similar to that of the non-enzyme producers; this was largely unaffected by the inoculum level used. When the MICs of 3-lactam antibiotics against strains of Proteus are determined at high inoculum concentrations, problems arise associated with the osmolality of the growth medium. In a miedium of high osmolality the growth of the organisms is arrested, but they do not lyse. This effect is shown in Fig. 4 , the lytic effect occurring in the medium of lower osmolality.
The correlation between enzyme resistance and good antibacterial activity was not absolute with cefuroxime, and some discrepancies were seen with Serratia and some strains of indole-positive Proteus. In conventional tests with partially purified enzyme preparations, cefuroxime appeared to be stable to these 38-lactamases, but it did not give good MICs against a number of these strains. This was attributed to very slow hydrolysis of the compound by cell-bound 83-lactamases over the 18-h incubation period, tolerance of the organisms for the compound, or its failure to penetrate to the active site in the cells. Discrepancies of a similar nature between enzyme resistance and antibacterial activity have also been reported for cefoxitin (6, 10) .
Many of the indole-positive Proteus strains showing relative, resistance to cefuroxime gave unexpectedly large zones in the disk sensitivity tests, which suggests that the organisms are not fundamentally resistant to cefuroxime and that it can affect their growth under these conditions.
Cefuroxime was also apparently stable to attack by the 4-lactamase produced by P. aeruginosa, but the compound was inactive against strains of this organism. On the other hand, although cefuroxime is not very resistant to the f8-lactamase produced by the Klebsiella strains (Table 5) , it was active against more than 75% of these organisms at 16 gg/ml or less, including many /8-lactamase-producing strains, and gave good zones in the disk sensitivity test. It is evident that inhibition of any Unlike the majority of cephalosporins, cefuroxime was highly active against strains of H. influenzae, and this activity was maintained against the ampicillin-resistant strains that have recently been reported (4, 13) . Ampicillin resistance among strains of H. influenzae is almost certainly due to the production of a class III /3-lactamase (12) , to which cefuroxime is completely stable ( Table 5) .
The high activity of cefuroxime against strains of N. gonorrhoeae and N. meningitidis is again an unusual attribute of the cephalosporins, cefuroxime being of the order of 100-fold more active than cephalothin against these organisms. In its activity against strains of H. influenzae and Neisseria spp. cefuroxime is very similar to cephamandole (3) .
From these preliminary studies with cefuroxime it appears that stability to 3-lactamases produced by gram-negative organisms is important in determining the breadth of the spectrum and the antibacterial effectiveness of a compound. It is also advantageous for the compound to be lytic and to be able to kill bacterial cells rapidly at low concentrations. Cefuroxime fulfills these criteria.
Cefuroxime shows a low degree of binding to human serum proteins, so it is likely that the majority of circulating antibiotic in the body will be available to exert its antibacterial effect, unlike compounds such as cefazolin, which are highly serum bound (8) .
Its stability in the presence of mammalian liver homogenates is also an advantage in that the compound will be metabolically stable in the body and thus its antibacterial activity will not be impaired. (Table 2 ) and the data presented in Fig. 2 
